Teleflex (NYSE:TFX) Shares Gap Down – What’s Next?

Teleflex Incorporated (NYSE:TFX)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $126.53, but opened at $112.50. Teleflex shares last traded at $113.3870, with a volume of 720,314 shares changing hands.

Wall Street Analysts Forecast Growth

TFX has been the topic of a number of recent analyst reports. Wells Fargo & Company boosted their price target on Teleflex from $114.00 to $139.00 and gave the stock an “equal weight” rating in a research report on Wednesday, December 10th. Royal Bank Of Canada reiterated a “sector perform” rating and set a $135.00 target price on shares of Teleflex in a research note on Wednesday, December 17th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Tuesday, December 9th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Finally, Truist Financial lifted their price objective on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research report on Thursday, December 18th. One investment analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Teleflex currently has an average rating of “Reduce” and a consensus target price of $142.43.

Teleflex Stock Up 2.7%

The company has a quick ratio of 1.53, a current ratio of 2.57 and a debt-to-equity ratio of 0.67. The company has a market cap of $4.99 billion, a price-to-earnings ratio of -15.37, a P/E/G ratio of 1.23 and a beta of 0.93. The stock has a fifty day moving average price of $118.26 and a two-hundred day moving average price of $121.12.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, topping analysts’ consensus estimates of $3.38 by $0.29. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The business had revenue of $892.90 million for the quarter, compared to analyst estimates of $892.79 million. During the same period last year, the firm earned $3.49 earnings per share. Teleflex’s revenue for the quarter was up 19.4% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, sell-side analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 14th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date was Friday, November 14th. Teleflex’s payout ratio is presently -18.50%.

Hedge Funds Weigh In On Teleflex

A number of hedge funds have recently added to or reduced their stakes in the stock. United Services Automobile Association acquired a new stake in shares of Teleflex during the 1st quarter worth $373,000. Empowered Funds LLC lifted its position in Teleflex by 15.8% during the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock worth $233,000 after purchasing an additional 230 shares during the period. Jane Street Group LLC lifted its position in Teleflex by 42.6% during the first quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock worth $877,000 after purchasing an additional 1,895 shares during the period. IFM Investors Pty Ltd grew its stake in Teleflex by 7.8% during the first quarter. IFM Investors Pty Ltd now owns 8,311 shares of the medical technology company’s stock worth $1,148,000 after buying an additional 602 shares in the last quarter. Finally, Strs Ohio bought a new position in Teleflex in the 1st quarter valued at about $3,040,000. Institutional investors own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.